Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Rectal Neoplasms 3 Biliary Tract Neoplasms 3 Uterine Cervical Neoplasms 2 Nasopharyngeal Carcinoma 2 Gastrointestinal Stromal Tumors 2 Colonic Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Thymoma 1 Stomach Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rare Tumour 1 Prostatic Neoplasms 1 Piebaldism 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Multiple Primary 1 Neoplasm Metastasis 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Locally Advanced Rectal Carcinoma 1 HER2-positive Breast Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1

Interventions

envafolimab 1 Radiotherapy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms, Multiple Primary × envafolimab × Clear all

NCT04182789 2019-12-02

CPOG035-01

RenJi Hospital

Phase 2 Unknown

Neoplasms, Multiple Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡